ClinicalTrials.govpublic full text
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children
heart transplantation, cardiac disease, regulatory t cell, immunomodulation, tolerogenic protocol, immunosuppressive agents, immunologic factors, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 879150
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.